MedTrace Logo

An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

NCT01608659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2019-04-17

Study results available
· View outcomes & findings →

Summary

This is a retrospective chart review to evaluate treatment patterns of botulinum toxin Type A for the treatment of facial lines.

Conditions

  • Facial Rhytides

Interventions

DRUG

botulinum toxin Type A

Previous treatment with botulinum toxin Type A for treatment of facial lines

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-01
Primary Completion
2011-06-17
Completion
2011-06-17

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01608659 on ClinicalTrials.gov